15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Evolus Inc, 4 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $13.00 to $22.00, a moderate spread. The average target of $16.80 sits 170% above the current $6.23. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.07 next quarter toward $0.24 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Strong Buy
Strong Buy00%
Buy480%
Hold120%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Evolus Inc.
As of Jul, 4 of 5 firms rate EOLS a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
EOLS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.07
Range $-0.09 – $-0.05 · 3 analysts · -53% YoY
Next period, 3 analysts expect Evolus Inc to earn $-0.07 a share (range $-0.09 – $-0.05), versus $-0.15 a year earlier. Full-year consensus is $-0.09, growing to $0.24 the year after.
REVENUE · NEXT QUARTER
$77.3M
Range $76.0M – $79.1M · 3 analysts · +12% YoY
Revenue is expected to reach $77.3M (range $76.0M – $79.1M), +12.1% year-over-year. Full-year consensus is $330.5M, rising to $387.7M next year.
Top analysts covering Evolus Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EOLS.
#1
Serge Belanger
Needham · Rank #83
Hold
No targeton EOLS
Overall win rate
48%
+ Follow
#2
Balaji Prasad
Barclays · Rank #147
Buy
$25.00+301.3% to target
Overall win rate
44%
+ Follow
#3
Louise Chen
Cantor Fitzgerald · Rank #156
Buy
No targeton EOLS
Overall win rate
43%
+ Follow
#4
Douglas Tsao
HC Wainwright & Co. · Rank #212
Buy
$13.00+108.7% to target
Overall win rate
35%
+ Follow
#5
SE
Sam Eiber
BTIG
Buy
$13.00+108.7% to target
Coverage
—
+ Follow
EOLS stock forecast FAQ
What is EOLS's average 12-month price target?+
The 4 analysts with a live target average $16.80 for Evolus Inc over the next 12 months, ranging from a $22.00 high to a $13.00 low.
Is EOLS stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 5 analyst ratings, 4 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for EOLS?+
The Street-high target is $22.00, and the Street-low is $13.00 (BTIG). The average of all 4 active targets is $16.80.
How many Wall Street analysts cover EOLS?+
5 analysts have an active rating on Evolus Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering EOLS?+
Among analysts who currently cover EOLS, Serge Belanger of Needham has the strongest overall Quantellect track record (Rank #83). Their current call is Hold.
What is Evolus Inc's projected EPS for next quarter?+
The consensus estimate is $-0.07 per share (range $-0.09 – $-0.05) across 3 analysts. Full-year EPS is projected at $-0.09, rising to $0.24 the following year.
How much revenue is Evolus Inc expected to report next quarter?+
Consensus revenue is $77.3M (range $76.0M – $79.1M). Full-year revenue is projected at $330.5M, growing to $387.7M next year.
Have analysts been upgrading or downgrading EOLS lately?+
As of Jul, 4 of 5 firms rate EOLS a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EOLS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
